TrialAnnals of surgery2011

StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

John M Centanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.